Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

194 results
Display

Serum 25-Hydroxy Vitamin D Levels and Association of Vitamin D Receptor Gene Polymorphisms in Vitiligo

Kim TE, Kim SK, Shin MK, Jeong KH, Lee MH

Background: The role of vitamin D deficiency and vitamin D receptor (VDR) gene polymorphisms has been established in many autoimmune diseases, including vitiligo, but the result is still controversial. Objectives: The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Results of Tissue Grafting in Vitiligo: A Single-Center Retrospective Analysis for 11 Years

Roh WS, Park J, Park S, Oh SH

  • KMID: 2526765
  • Korean J Dermatol.
  • 2022 Feb;60(2):82-90.
Background: Vitiligo is an acquired depigmentary disorder characterized by the destruction of melanocytes via an autoimmune-mediated process. Treatments can be categorized into nonsurgical and surgical methods. Prognostic factors of surgical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Patients’ Perspectives Regarding Vitiligo on Social Media: A Web Scraping Study from the Open Internet Community

Kim SH, Lee RW, Lee SG, Ju HJ, Lee JH, Kim GM, Bae JM

  • KMID: 2509667
  • Korean J Dermatol.
  • 2020 Dec;58(10):656-661.
Background: In recent years, large amounts of data generated by patients have been accumulated on social media. We explored patients’ perspectives and experiences with vitiligo using web scraping data from the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgical interventions for vitiligo

Bae JM, Ju HJ

Since nonsurgical treatment of vitiligo is not always successful, surgical interventions are viable options for patients with refractory vitiligo. Surgical treatment is a method in which melanocytes of normal skin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-surgical treatment of vitiligo

Choi CW

Vitiligo is an acquired depigmenting skin disorder that affects 0.5% to 2% of the population. Skin lesions from vitiligo, white macules and patches on the skin, can pose a substantial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Classification and diagnosis of vitiligo

Oh SH

Vitiligo is a relatively common, acquired hypopigmentary disorder caused by the loss of epidermal melanocytes. It is characterized by asymptomatic, well-circumscribed round to oval-shaped whitish patches that vary in size....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathogenesis of vitiligo

Seok SH, Kim DH

Vitiligo is an autoimmune disease in which CD8+ T-cells target and destroy melanocytes, leaving areas of skin without pigment production. Nonsegmental vitiligo, the classical form of the disease, results in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets

Li L

Vitiligo is an acquired skin disorder clinically characterized by the progressive appearance of white maculae due to a loss of functioning epidermal melanocytes. Studies have shown that microRNAs (miRNAs) modulate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hair Follicle as a Source of Pigment-Producing Cells for Treatment of Vitiligo: An Alternative to Epidermis?

Ghasemi M, Bajouri A, Shafiiyan S, Aghdami N

To discuss the advantages and limitations of hair follicle-derived cell transplantation (FCT) in vitiligo, compared to the epidermal cell transplantation (ECT), and the knowledge gap which is required to be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Inflammatory Vitiligo with Raised Borders

Choi H, Kim YI, Na CH, Kim MS, Shin BS

  • KMID: 2506589
  • Korean J Dermatol.
  • 2020 Sep;58(8):554-557.
Inflammatory vitiligo with raised borders (IVRB) is characterized by central hypopigmented patches with pruritic erythematous raised borders. It is important as it may be a clinical sign associated with the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple Actinic Keratoses within Vitiliginous Patches in a Patient with Non-segmental Vitiligo

Shin J, Kim DY, Park S, Koo JS, Hann SK, Oh SH

  • KMID: 2501396
  • Korean J Dermatol.
  • 2020 Jan;58(1):39-42.
A 74-year-old man visited our department with complaints of multiple asymptomatic erythematous scaly crusted patches on the scalp. He had non-segmental vitiligo with the extent of over 20% of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Micropigmentation for Acral Vitiligo: An Open-label Pilot Study of 12 Patients

Eun SH, Lee HN, Kim SH, Lee RW, Ju HJ, Lee JH, Kim GM, Bae JM

  • KMID: 2501393
  • Korean J Dermatol.
  • 2020 Jan;58(1):20-25.
Background: Micropigmentation is a medical tattooing procedure in which pigments are implanted into the superficial dermis using a manual or electrically driven needle. Objective: We aimed to assess the benefit and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata

Zhang L, Xu X, Chen S, Kang Y, Wang X, Zhang C, Xiang L

BACKGROUND: Vitiligo is a common acquired pigmentary disease caused by destruction of epidermal melanocytes in underlying autoimmune response. Few studies have been focused on the role of chemokines in non-segmental...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vitiligo with Leukotrichia Following Topical Diphenylcyclopropenone Immunotherapy for Acute Diffuse and Total Alopecia

Park JB, Seong SH, Jang JY, Yang MH, Kim JH, Suh KS, Sim WY, Jang MS

  • KMID: 2440729
  • Korean J Dermatol.
  • 2019 Feb;57(2):94-96.
Leukotrichia is defined as depigmentation of hair within vitiligo macules and is considered indicative of the destruction of the melanocyte reservoir within the hair follicle. A 15-year-old woman with acute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vitiligo in a Patient with Systemic Lupus Erythematosus: A Case Report

Kwon HI, Oh EH, Jung YD, Ko JY

  • KMID: 2437055
  • Korean J Dermatol.
  • 2018 Dec;56(10):620-623.
Vitiligo is a multifactorial disorder. Neural, biochemical, and autoimmune mechanisms have been hypothetically suggested as etiopathological contributors to this condition. Autoimmunity focuses primarily on genetic factors and the association between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concurrence of Circumscribed Morphea and Segmental Vitiligo: A Case Report

Lee JS, Park HS, Cho S, Yoon HS

Although a few reports have noted the concurrent presentation of morphea and vitiligo at distinctly separate sites in the same patient, it is extremely rare that these two conditions occur...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Refractory Vitiligo Treated with Non-cultured Epidermal Cell Suspension Transplantation Using Suction Blister Method

Eun SH, Jung YS, Lee H, Lee JH, Kim GM, Bae JM

  • KMID: 2436997
  • Korean J Dermatol.
  • 2018 Nov;56(9):552-555.
Vitiligo is a commonly acquired cutaneous depigmentation disorder that affects 0.5~1% of the population worldwide. While phototherapy is the primary treatment for vitiligo, surgical methods can be used for treating...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Segmental Vitiligo Occurring Where Herpes Zoster Occurred Previously as an Isotopic Response

Kim JY, Lee YH, Lim JY, Choi JY, Min JH, Choi YJ, Nam JH, Kim WS, Lee GY

  • KMID: 2436995
  • Korean J Dermatol.
  • 2018 Nov;56(9):543-547.
Wolf's isotopic response is defined as the occurrence of a new skin disorder at the site of another unrelated skin disease that has already healed. In most cases of isotopic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo

Abdou AG, Maraee A, Yassien H, Sarhan M

BACKGROUND: Vitiligo is a chronic autoimmune disease in which the destruction of melanocytes causes white spots on the affected skin. Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream

Kim NH, Lee JB, Yun SJ

A 69-year-old man presented with a black irregular patch on his left cheek. Skin biopsy revealed lentigo maligna melanoma in situ. He was treated via partial excision of the melanoma,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr